Excitatory amino acid receptor antagonists
US6924294B2 · kind B2 · utility
0Cited by
3References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2001 |
| Grant date | Aug 2, 2005 |
| Priority date | — |
| Expiry date | Mar 25, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/26
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds of Formula (I), or the pharmaceutically acceptable salts or prodrugs thereof, and methods for treating neurological disorders and neurodegenerative diseases, particularly pain and migraine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.